Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
Clínica Baviera runs eye-care clinics across Europe, and its newest clinics tend to pay back quickly while the core business keeps growing through repeat referrals and a strong brand. The big question is whether the market is missing how resilient this model can be even as Germany and the UK face short-term pressure.Read more
A Debt-Free PGM Producer Trading at 2x EBITDA With a 10% Dividend Yield Nobody Is Talking About
A little-known platinum producer in South Africa is throwing off cash and paying a big dividend, yet the market still treats it like it’s in trouble. See what’s driving the strong results, what could unlock a re-rating, and the key risks—from metal price swings to project ramp-up and local operating challenges.Read more
The Market Is Paying You a 9.3% Dividend and an 18.9% FCF Yield to Wait for a Recovery That's Already Starting
Betsson’s share price is dragged down by a sudden drop in activity from one major platform client, even as its main online casino and sports betting business keeps adding customers and expanding in regulated markets. The story hinges on whether that one-off setback fades and new growth drivers kick in—while calling out the key regulatory and currency risks to watch.Read more
A Compelling Compounder at a Retailer's Multiple
Watches of Switzerland gets treated like a normal shop, but its real edge is being a key gateway for hard-to-get luxury watches in the fast-growing US market. The story also hinges on a newer jewellery arm that could quietly lift the whole business, while the biggest question is how secure its ties to Rolex really are.Read more
Is It worth SEK 16? Arbitrage opportunity?
A new investor-backed share issue points to a much higher value than where the company has been trading, raising the question of whether the market will catch up. The company also plans to buy a cash-generating payments fintech using shares, but the heavy dilution and the motives behind the deal could change how this plays out.Read more
A Monopoly-Quality Business Trading at Distress Multiples — CEO Buying, €346M Buyback Active, 73% Upside to Fair Value
Evolution sells the behind-the-scenes live casino software that many online betting brands rely on, and the market is treating it like a business in trouble even though it keeps throwing off cash and buying back its own shares. The big question is whether recent weakness in Europe and shaky exposure to unregulated parts of Asia prove temporary—or become lasting damage.Read more
Deep Value Multi Bagger Opportunity
A little-known spinoff with equipment tied to gas projects in Papua New Guinea looks priced as if it may never get busy again, even though it sits on cash and has no debt. The big question is whether a long-awaited project decision restarts work—and whether management can be trusted to treat everyday shareholders fairly.Read more
Every Staffing Stock Is Being Sold. SThree Is the Only One That Benefits From the Thing Killing the Others
Most staffing firms fear that automation will shrink hiring, but SThree argues it serves the specialist engineers and tech experts that companies need even more as they roll out new AI and energy projects. The story hinges on whether a recent tech overhaul and early signs of recovery in some regions can outweigh a prolonged slump in Europe and a likely dividend cut.Read more
Seacrest Petroleo Bermuda is worth 0
Everything that could have gone wrong, went wrong. The assets are now owned by the bank and creditors Poorly managed company with very slow decission making , unable to react that have wasted a Great future.Read more